FDA
Home Page | CDRH Home Page | Search
| CDRH
A-Z Index | Contact CDRH
|
PMA Final Decisions Rendered for October 2000 |
A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available. Information about the PDF Reader is available.
APPLICATION NUMBER / DATE of APPROVAL |
DEVICE TRADE NAME |
COMPANY NAME, CITY, STATE, & ZIP |
DEVICE DESCRIPTION / INDICATIONS |
10/13/00 |
ATS Open Pivot® Bileaflet Heart Valve |
ATS Medical, Inc. Minneapolis, MN 55447 |
Approval for the ATS Open Pivot® Bileaflet Heart Valve, Standard Aortic Model 500FA 21, 23, 25, 27, and 29 mm, Standard Mitral Model 500DM 29, 31, and 33 mm, Advanced Performance (AP) Aortic Model 501DA 18, 20, 22, 24, and 26 mm, and AP Mitral Model 501DM 26 and 28 mm. The device is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic or mitral valves. |
10/12/00 |
HealthTronics OssaTron® |
HealthTronics, Inc. Marietta, GA 30062 |
Approval for the OssaTron. The device is indicated for use for performing extracorporeal shock wave (ESW) treatment in patients with chronic proximal plantar fasciitis that has failed to respond to conservative treatment. Chronic proximal plantar fasciitis is defined as pain in the area of the insertion of the plantar fascia on the medial calcaneal tuberosity that has persisted for 6 months or more. |
10/20/00 |
Nucleus 24 Auditory Brainstem Implant (ABI) System |
Cochlear Corporation Englewood, CO 80112 |
Approval for the Nucleus 24 Auditory Brainstem Implant (ABI) System. The device is intended to restore useful hearing via electrical stimulation of the cochlear nucleus. The device is indicated for individuals 12 years of age or older, who have been diagnosed with Neurofibromatosis Type 2 (NF2). Implantation may occur during first or second-side tumor removal, or in patients with previously removed acoustic tumors bilaterally. Because the surgical procedure for tumor excision and electrode placement eliminates residual hearing preoperative audiological criteria are not relevant. Prospective implant recipients and their families should have appropriate expectations, regarding the potential benefits of an auditory brainstem implant and should be highly motivated to participate in the postoperative rehabilitation process. |
10/16/00 |
Medtronic AVE BeStent™ 2 with Discrete Technology™ Over-the-Wire (OTW) & Rapid Exchange (RX) Coronary Stent Delivery Systems |
Medtronic AVE Inc. Santa Rosa, CA 95403 |
Approval for the Medtronic AVE BeStent™ 2 with Discrete Technology™ Over-the-Wire (OTW) Coronary Stent Delivery System and the Medtronic AVE BeStent™ 2 with Discrete Technology™ Rapid Exchange (RX) Coronary Stent Delivery System. The devices are indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to discrete de novo lesions (length £ 30 mm) in native coronary arteries with reference vessel diameters ranging from 3.0 mm to 4.0 mm. |
PMA SUPPLEMENTAL APPROVALS | |||
APPLICATION NUMBER / DATE of APPROVAL |
DEVICE TRADE NAME |
COMPANY NAME |
DEVICE DESCRIPTION / INDICATIONS |
10/16/00 Panel-Track |
Gelfoam® Sterile Powder |
Pharmacia & Upjohn Company Kalamazoo, MI 49001 |
Approval for the addition of bone hemostasis to the indications for use. |
P810002/S054 10/23/00 Real-Time |
SJM® Master Series Hemodynamic Plus (HP) with Flex Cuff™, Model AFHPJ-505 |
St. Jude Medical, Inc. St. Paul, MN 55117 |
Approval for a change to the aortic polyester cuff configuration of the SJM® Master Series HP valve. The device, as modified, will be marketed under the trade name SJM® Master Series Hemodynamic Plus (HP) with Flex Cuff™, Model AFHPJ-505, available in aortic sizes 17, 19, 21, 23, 25, and 27 mm. |
P830045/S072 10/2/00 Real-Time |
Integrity AFx DR Model 5342 and SR Model 5142 |
St. Jude Medical Sylmar, CA 91342 |
Approval for modifications to the users manuals for the Integrity AFx DR Model 5342 and SR Model 5142. |
P860019/S162 10/5/00 180-Day |
Boston Scientific Scimed MAVERICK™ Over-The-Wire (OTW) Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter |
Boston Scientific Scimed, Inc. Maple Grove, MN 55311 |
Approval for the Boston Scientific Scimed MAVERICK™ Over-the-Wire (OTW) Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter (9, 12, 15, 20, 25 and 30 mm lengths with balloon diameters of 2.0 – 4.0 mm in ¼ mm increments, and 9, 15 and 20 mm lengths with balloon diameters of 1.5 mm). The MAVERICK™ OTW PTCA Catheter is indicated for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion. The MAVERICK™ OTW PTCA Catheter (2.25 – 4.0 mm balloon diameters) is also indicated for the post-delivery expansion of balloon expandable stents. |
P880086/S078 10/2/00 Real-Time |
Integrity AFx DR Model 5342 and SR Model 5142 |
St. Jude Medical Sylmar, CA 91342 |
Approval for modifications to the users manuals for the Integrity AFx DR Model 5342 and SR Model 5142. |
P890003/S061 10/2/00 Real-Time |
Model 9790/9790C Programmer |
Medtronic, Inc. Shoreview, MN 55126 |
Approval for modification of labeling regarding the VGA video output port on the Model 9790/9790C series programmers, which instructs users to contact Medtronic technical services for guidance in using the port. |
P900056/S055 10/5/00 Special |
Rotablator® Rotational Angioplasty System |
Boston Scientific Corporation Redmond, WA 98052 |
Approval for a quality control change for receiving inspection to inspect the shuttle spring for sharp edges. |
P900056/S056 10/24/00 180-Day |
Rotablator® Rotational Angioplasty System with RotaLink Plus Exchangeable |
Boston Scientific Corporation Redmond, WA 98052 |
Approval for an additional manufacturing site located at Boston Scientific Cork, Ltd, Cork, Ireland and additional sterilization facility located at Isotron Ireland Ltd., Offaly, Ireland. |
10/27/00 Panel-Track |
Photon™ DR Implantable Cardioverter Defibrillator (ICD) System |
St. Jude Medical, Inc. Sunnyvale, CA 94086 |
Approval for the Photon™ DR ICD System including the Pulse Generator, (Model V-230HV), Model 3307, V1.3 Programmer Software, Model AC-IP IS-1 Receptable Plug, and Model 442-2 Torque Driver/Torque Wrench. This device is indicated for use in patients with a history of hemodynamically compromising ventricular tachyarrhythmias. These patients may have experienced a cardiac arrest not associated with acute myocardial infarction or have ventricular tachyarrhythmias. In addition, the pulse generator can be used in patients whose primary therapy for hemodynamically significant, sustained ventricular tachycardia is antitachycardia pacing; the defibrillation capabilities of the device provide high-energy therapy in the event that the arrhythmia accelerates. The pulse generator can be implanted in either the pectoral region or the abdominal region, at the physician’s discretion. |
P910073/S032 10/5/00 Real-Time |
ENDOTAK® RELIANCE™ Models 147, 148, 149 and RELIANCE S™ Models 127, 128, 129 Endocardial Defibrillation Leads with Accessory Stylet Models 6771 and 6772 |
Guidant Corporation St. Paul, MN 55112 |
Approval for the ENDOTAK family of defibrillation leads and the accessory stylet kit. |
P910073/S036 10/12/00 Real-Time |
Lead Tunneler Kit Model 6888 |
Guidant Corporation St. Paul, MN 55112 |
Approval for Model 6888 Lead Tunneler Kit after replacing Tunneling Tip Model 6995 with Model 6804 (used with the ENDOTAK RELIANCE / RELIANCE S Leads) |
P920014/S013 10/20/00 Real-Time |
TCI HeartMate® VE LVAS |
Thermo Cardiosystems, Inc. Woburn, MA 01888 |
Approval to modify the HeartMate VE System Controller (C/N 1215) to accommodate a new four cell Battery Module (Battery Cell), resulting in VE System Controller C/N 1216 and Battery Module C/N 1264. |
10/18/00 Panel Track |
VISX STAR S2 and S3 Excimer Laser Systems |
VISX, Inc. Santa Clara, CA 95051 |
Approval for the VISX STAR S2 and S3 Excimer Laser Systems which are indicated for photorefractive keratectomy (PRK) treatments: 1) in patients with documented evidence of a change in manifest refraction of less than or equal to 0.5 D (in both cylinder and sphere components) per year for at least one year prior to the date of pre-operative examination; and 2) in patients 21 years of age or older for the reduction or elimination of naturally occurring hyperopia between +0.5 and +5.0 D sphere at the spectacle plane with refractive astigmatism from +0.5 to +4.0 D with a maximum manifest refraction spherical equivalent (MRSE) of +6.0 D. |
P930038/S027 10/31/00 180-Day |
Angio-Seal™ EV Vascular Closure Device, 6 and 8 French |
St. Jude Medical Minnetonka, MN 55345 |
Approval for a device name modification and longer guidewire. The device, as modified, will be marketed under the trade named Angio-Seal™ EV Vascular Closure Device and is indicated for femoral arterial access closure following 8F and 6F diagnostic angiography and interventional (8F only) procedures. |
P940008/S015 10/5/00 Real-Time |
Lead Cap Accessory Kit Model 6623 |
Guidant Corporation St. Paul, MN 55112 |
Approval for the Lead Caps for use with all Guidant compatible leads including the RELIANCE™ and RELIANCE S™ Leads. |
P950029/S010 10/10/00 Real-Time |
Talent and Brio Pacemakers |
ELA Medical Plymouth, MN 55441 |
Approval to change the header material in the Talent and Brio pacemakers. |
P950029/S011 10/11/00 Real-Time |
Brio Pulse Generators |
ELA Medical Plymouth, MN 55441 |
Approval for the following modifications to the Brio family of pacemakers: 1) modify the value for the number of cycles the device will allow before a self test is initiated when the sensor "calls for an elevated pacing rate for a duration or frequency that exceeds reasonable physiologic limits" from 30,000 to 100-000 cycles; and 2) changing the minimum sensing threshold during T-wave protection from 2.2 to 2.5mV. |
P950037/S013 10/13/00 180-Day |
Actros SLR+ Pulse Generators |
BIOTRONIK, Inc. Lake Oswego, OR 97035 |
Approval for removal of the warning label which recommended programming Dynamic Hysteresis On when the device is programmed to the VDDR mode. |
P950037/S016 10/31/00 Real-Time |
Philos Family of Pulse Generators |
Biotronik, Inc. Lake Oswego, OR 97035 |
Approval for the use of alternative components in the Philos Family of Pulse Generators, specifically: 1) the LITRONIK GmbH & Co Model LiS 3150 Battery; and 2) a Low Temperature Co-fire Ceramic (LTCC) substrate. |
P960043/S027 10/17/00 Real-Time |
The Closer S 6 Fr. Suture Mediated Closure (SMC) System and The Closer 6 Fr. Suture Mediated Closure (SMC) System |
Perclose, Inc. Redwood City, CA 94063 |
Approval for the Knot Pusher with Trimmer, an accessory to The Closer 6 Fr. SMC System and The closer S 6 Fr. SMC System. |
P970004/S009 10/18/00 180-Day |
Medtronic® Interstim® System for Urinary Control (Model 3095A lead Extension Kit and Associated Labeling) |
Medtronic, Inc. Minneapolis, MN 55421 |
Approval for the Model 3095A Lead Extension Kit for use with the MEDTRONIC® Interstim® System for Urinary Control, which is indicated for the treatment of urinary urge incontinence, urinary retention, and significant symptoms of urgency/frequency in patients who have failed or could not tolerate more conservative treatments. |
P970020/S023 10/3/00 180-Day |
ACS Multi-Link RX and OTW Tetra™ Coronary Stent Systems |
Guidant Corporation Santa Clara, CA 95052 |
Approval for the ACS Multi-Link RX and OTW Tetra™ Coronary Stent Systems. The devices are indicated for improving coronary lumen diameter in the following: 1) Patients with symptomatic ischemic disease due to discrete de novo or restenotic native coronary artery lesions (length £ 25 mm) with a reference vessel diameter of 3.0 mm to 4.0 mm; and 2) treatment of abrupt or threatened abrupt closure in patients with failed interventional therapy in lesions (£ 35 mm in length) with reference diameters in the range of 2.5 mm to 4.0 mm. Long term outcome for this permanent implant is unknown at present. Note: The 2.5 mm and 2.75 mm diameter stents and the 33 mm and 38 mm length stents are solely indicated for use in patients with abrupt or threatened abrupt closure. |
P970053/S003 10/25/00 180-Day |
Nidek EC-5000 Excimer Laser System |
Nidek Technilogies, Inc. Pasadena, CA 91105 |
Approval for the incorporation of the nomogram for laser in-situ keratomileusis (LASIK) treatments into the Nidek EC-5000 software, along with the nomogram for PRK for moderate myopia with astigmatism. |
P980008/S002 10/27/00 180-Day |
LaserScan LSX Excimer Laser |
LaserSight Technologies, Inc. Winter Park, FL 32792 |
Approval for a manufacturing site located at LaserSight Technologies, Inc. Winter Park, Florida. |
P980035/S008 10/10/00 Real-Time |
Medtronic Sigma Pacing System and Medtronic 350 Series pacing System |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for modifications/improvements for the Sigma and 350 Pacing Systems, specifically: 1) Modify the bottom of the connector by adding a 0.020 recess on the underside area between the connector and the can. 2) Add notches to the skirt on the bottom of the connector. 3) Change interconnect ribbon (ICR) material 4) Modify connector ICR area by adding walls between interconnect ribbons. 5) Modify ICR weld configuration. 6) Change material for set screw blocks. 7) Modify 3.2 mm connector bores by modifying the location of the IS-1 lead stop zones. 8) Increase polyurethane thickness on outside of connector in ultrasonic weld zones. 9) Preformed ICRs. 10) Minimum adhesive fill line added around the perimeter of the fill area. |
P990017/S008 10/16/00 Special |
Ancure Endovascular Grafting System |
Guidant Cardiac and Vascular Surgery Group Menlo Park, CA 94025 |
Approval for enhancements to the manufacturing process for the Ancure System. |
30-DAY NOTICES (***135 Day Supplement Was Not Required) | |||
APPLICATION NUMBER & LTR DATE | DEVICE TRADE NAME | COMPANY NAME CITY, STATE, & ZIP | COMMENTS |
P930014/S008 10/23/00 |
AcrySof® Multi-piece Posterior Chamber Intraocular Lens (IOL), Models MA60BM & MA30BA |
Alcon Laboratories Fort Worth, TX 76134 |
Implementation of an automated final dimensional inspection station. |
P980001/S025 10/12/00 |
NIR Premounted Stent Systems |
Boston Scientific Scimed, Inc. Natick, MA 01760 |
Change to an in-process inspection step to remove the stent imprint as a rejection criterion for the elastomeric retaining sleeve component acceptance. |
Summary of PMA Originals & Supplements Approved
Originals:
4
Supplements: 26
Summary of PMA Originals Under Review
Total Under Review: 73
Total
Active: 34
Total On Hold: 39
Number Greater Than 180 Days: 0
Summary of PMA Supplements Under Review
Total Under Review:
190
Total Active: 108
Total On Hold: 82
Number Greater Than 180 Days:
4
Summary of All PMA Submissions Received
Originals: 3
Supplements:
40
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of
Approvals: 26
Number of Denials: 0
Average Days Fr Receipt to Decision
(Total Time): 102.2
FDA Time: 96.2 Days MFR Time: 6 Days
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH